Estrogen-dependent activation of neutral cholesterol ester hydrolase underlying gender difference of atherogenesis in apoE -/- mice

Atherosclerosis

Volumn 219, Issue 2, 2011, Pages 545-551

  Chiba, Tsuyoshi ^a,b   Ikeda, Masahiko ^a   Umegaki, Keizo ^b   Tomita, Takako ^a  

^a UNIVERSITY OF SHIZUOKA   (Japan)

^b NATIONAL INSTITUTE OF HEALTH AND NUTRITION   (Japan)

Author keywords

17 Estradiol (E2); A kinase type II; Atherosclerosis; N CEase

Indexed keywords

APOLIPOPROTEIN E; CHOLESTEROL; CHOLESTEROL ESTERASE; CONJUGATED ESTROGEN; CYCLIC AMP DEPENDENT PROTEIN KINASE 1; CYCLIC AMP DEPENDENT PROTEIN KINASE 2; ESTRADIOL; LIPID; LIPOPROTEIN; NEUTRAL CHOLESTEROL ESTER HYDROLASE; TRIACYLGLYCEROL; UNCLASSIFIED DRUG; VERY LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AORTA; AORTA ATHEROSCLEROSIS; ARTERY; ARTICLE; ATHEROGENESIS; ATHEROGENIC DIET; ATHEROSCLEROTIC PLAQUE; BODY WEIGHT; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; CYTOSOLIC FRACTION; ENZYME ACTIVATION; ENZYME ACTIVITY; FEMALE; LIPID BLOOD LEVEL; LIPOPROTEIN BLOOD LEVEL; MACROPHAGE; MALE; MOUSE; NONHUMAN; OVARIECTOMY; PERITONEUM MACROPHAGE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SEX DIFFERENCE; SHAM PROCEDURE; TRIACYLGLYCEROL BLOOD LEVEL; UTERUS WEIGHT;

ANIMALS; AORTA; AORTIC DISEASES; APOLIPOPROTEINS E; ATHEROSCLEROSIS; CELL LINE; CYCLIC AMP-DEPENDENT PROTEIN KINASE TYPE II; DISEASE MODELS, ANIMAL; ENZYME ACTIVATION; ESTRADIOL; ESTROGEN REPLACEMENT THERAPY; ESTROGENS, CONJUGATED (USP); FEMALE; LIPIDS; MACROPHAGES, PERITONEAL; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; OVARIECTOMY; PROTEIN TRANSPORT; SEX FACTORS; STEROL ESTERASE;

EID: 82955198485     PISSN: 00219150     EISSN: 18791484     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2011.08.051     Document Type: Article

References (35)

1. Kannel W.B., Hjortland M.C., McNamara P.M., Gordon T. Menopause and risk of cardiovascular disease: the Framingham study. Ann Intern Med 1976, 85:447-452.
2. Gordon T., Kannel W.B., Hjortland M.C., McNamara P.M. Menopause and coronary heart disease. The Framingham Study. Ann Intern Med 1978, 89:157-161.
3. Lerner D.J., Kannel W.B. Patterns of coronary heart disease morbidity and mortality in the sexes: a 26-year follow-up of the Framingham population. Am Heart J 1986, 111:383-390.
4. Ma P.T., Yamamoto T., Goldstein J.L., Brown M.S. Increased mRNA for low density lipoprotein receptor in livers of rabbits treated with 17 alpha-ethinyl estradiol. Proc Natl Acad Sci USA 1986, 83:792-796.
5. Lamon-Fava S., Ordovas J.M., Schaefer E.J. Estrogen increases apolipoprotein (apo) A-I secretion in hep G2 cells by modulating transcription of the apo A-I gene promoter. Arterioscler Thromb Vasc Biol 1999, 19:2960-2965.
6. Sulistiyani, Adelman S.J., Chandrasekaran A., Jayo J., St Clair R.W. Effect of 17 alpha-dihydroequilin sulfate, a conjugated equine estrogen, and ethynylestradiol on atherosclerosis in cholesterol-fed rabbits. Arterioscler Thromb Vasc Biol 1995, 15:837-846.
7. Williams J.K., Wagner J.D., Li Z., Golden D.L., Adams M.R. Tamoxifen inhibits arterial accumulation of LDL degradation products and progression of coronary artery atherosclerosis in monkeys. Arterioscler Thromb Vasc Biol 1997, 17:403-408.
8. Holm P., Shalmi M., Korsgaard N., et al. A partial estrogen receptor agonist with strong antiatherogenic properties without noticeable effect on reproductive tissue in cholesterol-fed female and male rabbits. Arterioscler Thromb Vasc Biol 1997, 17:2264-2272.
9. Bjarnason N.H., Haarbo J., Byrjalsen I., Kauffman R.F., Christiansen C. Raloxifene inhibits aortic accumulation of cholesterol in ovariectomized, cholesterol-fed rabbits. Circulation 1997, 96:1964-1969.
10. Brown M.S., Goldstein J.L. A receptor-mediated pathway for cholesterol homeostasis. Science 1986, 232:34-47.
11. Harte R.A., Hulten L.M., Lindmark H., et al. Low level expression of hormone-sensitive lipase in arterial macrophage-derived foam cells: potential explanation for low rates of cholesteryl ester hydrolysis. Atherosclerosis 2000, 149:343-350.
12. Ishii I., Ito Y., Morisaki N., Saito Y., Hirose S. Genetic differences of lipid metabolism in macrophages from C57BL/6J and C3H/HeN mice. Arterioscler Thromb Vasc Biol 1995, 15:1189-1194.
13. Cook K.G., Yeaman S.J., Stralfors P., Fredrikson G., Belfrage P. Direct evidence that cholesterol ester hydrolase from adrenal cortex is the same enzyme as hormone-sensitive lipase from adipose tissue. Eur J Biochem 1982, 125:245-249.
14. Small C.A., Goodacre J.A., Yeaman S.J. Hormone-sensitive lipase is responsible for the neutral cholesterol ester hydrolase activity in macrophages. FEBS Lett 1989, 247:205-208.
15. Anthonsen M.W., Ronnstrand L., Wernstedt C., Degerman E., Holm C. Identification of novel phosphorylation sites in hormone-sensitive lipase that are phosphorylated in response to isoproterenol and govern activation properties in vitro. J Biol Chem 1998, 273:215-221.
16. Small C.A., Rogers M.P., Goodacre J.A., Yeaman S.J. Phosphorylation and activation of hormone-sensitive lipase in isolated macrophages. FEBS Lett 1991, 279:323-326.
17. Tomita T., Sawamura F., Uetsuka R., et al. Inhibition of cholesterylester accumulation by 17 beta-estradiol in macrophages through activation of neutral cholesterol esterase. Biochim Biophys Acta 1996, 1300:210-218.
18. Alto N.M., Scott J.D. The role of A-Kinase anchoring proteins in cAMP-mediated signal transduction pathways. Cell Biochem Biophys 2004, 40:201-208.
19. Zhang S.H., Reddick R.L., Piedrahita J.A., Maeda N. Spontaneous hypercholesterolemia and arterial lesions in mice lacking apolipoprotein E. Science 1992, 258:468-471.
20. Chiba T., Uematsu S., Sawamura F., et al. Effects of phosphatidylcholine/phosphatidylethanolamine composition in cholesteryl ester-micellar substrates on neutral cholesterol esterase activity. Anal Biochem 1999, 268:238-244.
21. Reimann E.M., Beham R.A. Catalytic subunit of cAMP-dependent protein kinase. Methods Enzymol 1983, 99:51-55.
22. Escary J.L., Choy H.A., Reue K., Schotz M.C. Hormone-sensitive lipase overexpression increases cholesteryl ester hydrolysis in macrophage foam cells. Arterioscler Thromb Vasc Biol 1998, 18:991-998.
23. Zhao B., Song J., Chow W.N., et al. Macrophage-specific transgenic expression of cholesteryl ester hydrolase significantly reduces atherosclerosis and lesion necrosis in Ldlr mice. J Clin Invest 2007, 117:2983-2992.
24. Osuga J., Ishibashi S., Oka T., et al. Targeted disruption of hormone-sensitive lipase results in male sterility and adipocyte hypertrophy, but not in obesity. Proc Natl Acad Sci USA 2000, 97:787-792.
25. Contreras J.A. Hormone-sensitive lipase is not required for cholesteryl ester hydrolysis in macrophages. Biochem Biophys Res Commun 2002, 292:900-903.
26. Okazaki H., Igarashi M., Nishi M., et al. Identification of neutral cholesterol ester hydrolase, a key enzyme removing cholesterol from macrophages. J Biol Chem 2008, 283:33357-33364.
27. Sekiya M., Osuga J., Igarashi M., Okazaki H., Ishibashi S. The role of neutral cholesterol ester hydrolysis in macrophage foam cells. J Atheroscler Thromb 2011, 18:359-364.
28. Sekiya M., Osuga J., Nagashima S., et al. Ablation of neutral cholesterol ester hydrolase 1 accelerates atherosclerosis. Cell Metab 2009, 10:219-228.
29. Carr D.W., DeManno D.A., Atwood A., Hunzicker-Dunn M., Scott J.D. Follicle-stimulating hormone regulation of A-kinase anchoring proteins in granulosa cells. J Biol Chem 1993, 268:20729-20732.
30. McNeill A.M., Kim N., Duckles S.P., Krause D.N., Kontos H.A. Chronic estrogen treatment increases levels of endothelial nitric oxide synthase protein in rat cerebral microvessels. Stroke 1999, 30:2186-2190.
31. Geary G.G., McNeill A.M., Ospina J.A., et al. Selected contribution: cerebrovascular nos and cyclooxygenase are unaffected by estrogen in mice lacking estrogen receptor-alpha. J Appl Physiol 2001, 91:2391-2399. [discussion 2389-2390].
32. Nakano Y., Oshima T., Matsuura H., Kajiyama G., Kambe M. Effect of 17beta-estradiol on inhibition of platelet aggregation in vitro is mediated by an increase in NO synthesis. Arterioscler Thromb Vasc Biol 1998, 18:961-967.
33. Frazier-Jessen M.R., Kovacs E.J. Estrogen modulation of JE/monocyte chemoattractant protein-1 mRNA expression in murine macrophages. J Immunol 1995, 154:1838-1845.
34. Hogg N., Struck A., Goss S.P., et al. Inhibition of macrophage-dependent low density lipoprotein oxidation by nitric-oxide donors. J Lipid Res 1995, 36:1756-1762.
35. Elhage R., Bayard F., Richard V., et al. Prevention of fatty streak formation of 17beta-estradiol is not mediated by the production of nitric oxide in apolipoprotein E-deficient mice. Circulation 1997, 96:3048-3052.